Hemlibra 105 mg/.7mL
emicizumab · INJECTION, SOLUTION · Genentech, Inc.
No Recall History
Plain English
Hemlibra is a injection, solution containing emicizumab at 105 mg/.7mL, taken subcutaneous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Hemlibra
- Generic Name
- emicizumab
- NDC Code (Product)
50242-922- Manufacturer
- Genentech, Inc.
- Strength
- 105 mg/.7mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761083
- Marketing Start
- 11/16/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Hemlibra used for?
Hemlibra contains emicizumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Hemlibra a controlled substance?
Hemlibra is not classified as a controlled substance by the DEA.
What is the generic name for Hemlibra?
The generic name for Hemlibra is emicizumab. There are no other listed brand versions of emicizumab.
What is the NDC code for Hemlibra 105 mg/.7mL?
The NDC (National Drug Code) for Hemlibra 105 mg/.7mL is 50242-922, listed by Genentech, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)